Dostarlimab

June 2022 NYC Cancer Trial Delivers ‘Unheard-of' Result: Complete Remission for Everyone

Patients with a particular kind of cancer and a particular kind of mutation received a new therapy called dostarlimab and had results not seen in a cancer trial before